Investigating Association Between Inflammatory Bowel Disease and Rotavirus Vaccination in a Paediatric Cohort in the UK

Overview

Journal Epidemiol Infect

Publisher Cambridge University Press

Specialties Infectious Diseases
Public Health

Date 2023 Jun 9

PMID 37293971

Authors

Aidan Flatt

Thomas Inns

Kate M Fleming

Miren Iturriza-Gomara

Daniel Hungerford

Affiliations

Soon will be listed here.

Abstract

In the UK, the incidence and prevalence of inflammatory bowel disease (IBD) is increasing in paediatric populations. Environmental factors including acute gastroenteritis episodes (AGE) may impact IBD development. Infant rotavirus vaccination has been shown to significantly reduce AGE. This study aims to explore the association between vaccination with live oral rotavirus vaccines and IBD development. A population-based cohort study was used, analysing primary care data from the Clinical Practice Research Datalink Aurum. Participants included children born in the UK from 2010 to 2015, followed from a minimum of 6 months old to a maximum of 7 years old. The primary outcome was IBD, and the primary exposure was rotavirus vaccination. Cox regression analysis with random intercepts for general practices was undertaken, with adjustment for potential confounding factors. In a cohort of 907,477 children, IBD was recorded for 96 participants with an incidence rate of 2.1 per 100,000 person-years at risk. The univariable analysis hazard ratio (HR) for rotavirus vaccination was 1.45 (95% confidence interval (CI) 0.93-2.28). Adjustment in the multivariable model attenuated the HR to 1.19 (95% CI 0.53-2.69). This study shows no statistically significant association between rotavirus vaccination and development of IBD. However, it provides further evidence for the safety of live rotavirus vaccination.

References

Liles E, Irving S, Dandamudi P, Belongia E, Daley M, DeStefano F . Incidence of pediatric inflammatory bowel disease within the Vaccine Safety Datalink network and evaluation of association with rotavirus vaccination. Vaccine. 2021; 39(27):3614-3620. PMC: 8899860. DOI: 10.1016/j.vaccine.2021.05.032. View

Porter C, Tribble D, Aliaga P, Halvorson H, Riddle M . Infectious gastroenteritis and risk of developing inflammatory bowel disease. Gastroenterology. 2008; 135(3):781-6. DOI: 10.1053/j.gastro.2008.05.081. View

Porter C, Welsh M, Riddle M, Nieh C, Boyko E, Gackstetter G . Epidemiology of inflammatory bowel disease among participants of the Millennium Cohort: incidence, deployment-related risk factors, and antecedent episodes of infectious gastroenteritis. Aliment Pharmacol Ther. 2017; 45(8):1115-1127. DOI: 10.1111/apt.13991. View

Herrett E, Gallagher A, Bhaskaran K, Forbes H, Mathur R, van Staa T . Data Resource Profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol. 2015; 44(3):827-36. PMC: 4521131. DOI: 10.1093/ije/dyv098. View

Rodriguez L, Ruigomez A, Panes J . Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology. 2006; 130(6):1588-94. DOI: 10.1053/j.gastro.2006.02.004. View

Ashton J, Cullen M, Afzal N, Coelho T, Batra A, Beattie R . Is the incidence of paediatric inflammatory bowel disease still increasing?. Arch Dis Child. 2018; 103(11):1093-1094. DOI: 10.1136/archdischild-2018-315038. View

Lee S, Kwon J, Cho M . Immunological pathogenesis of inflammatory bowel disease. Intest Res. 2018; 16(1):26-42. PMC: 5797268. DOI: 10.5217/ir.2018.16.1.26. View

Lee W, Song Z, Wong S, Gan C, Koay Z, Em J . Environmental risk factors for inflammatory bowel disease: A case control study in Southeast Asian children. J Paediatr Child Health. 2021; 58(5):782-790. DOI: 10.1111/jpc.15830. View

Rosen M, Dhawan A, Saeed S . Inflammatory Bowel Disease in Children and Adolescents. JAMA Pediatr. 2015; 169(11):1053-60. PMC: 4702263. DOI: 10.1001/jamapediatrics.2015.1982. View

10.

Kuan V, Denaxas S, Gonzalez-Izquierdo A, Direk K, Bhatti O, Husain S . A chronological map of 308 physical and mental health conditions from 4 million individuals in the English National Health Service. Lancet Digit Health. 2019; 1(2):e63-e77. PMC: 6798263. DOI: 10.1016/S2589-7500(19)30012-3. View

11.

Walker J, Andrews N, Atchison C, Collins S, Allen D, Ramsay M . Effectiveness of oral rotavirus vaccination in England against rotavirus-confirmed and all-cause acute gastroenteritis. Vaccine X. 2019; 1:100005. PMC: 6668223. DOI: 10.1016/j.jvacx.2019.100005. View

12.

Hall E, Tippett A, Fridkin S, Anderson E, Lopman B, Benkeser D . Association Between Rotavirus Vaccination and Antibiotic Prescribing Among Commercially Insured US Children, 2007-2018. Open Forum Infect Dis. 2022; 9(7):ofac276. PMC: 9291383. DOI: 10.1093/ofid/ofac276. View

13.

Crawford S, Ramani S, Tate J, Parashar U, Svensson L, Hagbom M . Rotavirus infection. Nat Rev Dis Primers. 2017; 3:17083. PMC: 5858916. DOI: 10.1038/nrdp.2017.83. View

14.

Raffals L, Chang E . Navigating the Microbial Basis of Inflammatory Bowel Diseases: Seeing the Light at the End of the Tunnel. Gut Liver. 2016; 10(4):502-8. PMC: 4933408. DOI: 10.5009/gnl15491. View

15.

Baumgart D, Carding S . Inflammatory bowel disease: cause and immunobiology. Lancet. 2007; 369(9573):1627-40. DOI: 10.1016/S0140-6736(07)60750-8. View

16.

Hansen J . Immune Responses to Intestinal Microbes in Inflammatory Bowel Diseases. Curr Allergy Asthma Rep. 2015; 15(10):61. DOI: 10.1007/s11882-015-0562-9. View

17.

Hungerford D, Vivancos R, Read J, Iturriza-Gomara M, French N, Cunliffe N . Rotavirus vaccine impact and socioeconomic deprivation: an interrupted time-series analysis of gastrointestinal disease outcomes across primary and secondary care in the UK. BMC Med. 2018; 16(1):10. PMC: 5787923. DOI: 10.1186/s12916-017-0989-z. View

18.

Hungerford D, Vivancos R, Read J, Bonnett L, Bar-Zeev N, Iturriza-Gomara M . Mitigating bias in observational vaccine effectiveness studies using simulated comparator populations: Application to rotavirus vaccination in the UK. Vaccine. 2018; 36(45):6674-6682. DOI: 10.1016/j.vaccine.2018.09.051. View

19.

Loganathan T, Jit M, Hutubessy R, Ng C, Lee W, Verguet S . Rotavirus vaccines contribute towards universal health coverage in a mixed public-private healthcare system. Trop Med Int Health. 2016; 21(11):1458-1467. DOI: 10.1111/tmi.12766. View

20.

Ghosh N, Premchand P . A UK cost of care model for inflammatory bowel disease. Frontline Gastroenterol. 2017; 6(3):169-174. PMC: 5369575. DOI: 10.1136/flgastro-2014-100514. View